Structure Therapeutics Inc (GPCR)
41.92
+3.17
(+8.18%)
USD |
NASDAQ |
Sep 20, 16:00
41.85
-0.07
(-0.17%)
After-Hours: 20:00
Structure Therapeutics Price to Book Value: 2.603 for Sept. 20, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 20, 2024 | 2.603 |
| September 19, 2024 | 2.406 |
| September 18, 2024 | 2.376 |
| September 17, 2024 | 2.387 |
| September 16, 2024 | 2.484 |
| September 13, 2024 | 2.536 |
| September 12, 2024 | 2.502 |
| September 11, 2024 | 2.462 |
| September 10, 2024 | 2.138 |
| September 09, 2024 | 2.187 |
| September 06, 2024 | 2.295 |
| September 05, 2024 | 2.383 |
| September 04, 2024 | 2.352 |
| September 03, 2024 | 2.370 |
| August 30, 2024 | 2.368 |
| August 29, 2024 | 2.380 |
| August 28, 2024 | 2.444 |
| August 27, 2024 | 2.550 |
| August 26, 2024 | 2.521 |
| August 23, 2024 | 2.471 |
| August 22, 2024 | 2.431 |
| August 21, 2024 | 2.462 |
| August 20, 2024 | 2.501 |
| August 19, 2024 | 2.490 |
| August 16, 2024 | 2.305 |
| Date | Value |
|---|---|
| August 15, 2024 | 2.267 |
| August 14, 2024 | 2.250 |
| August 13, 2024 | 2.131 |
| August 12, 2024 | 2.060 |
| August 09, 2024 | 2.097 |
| August 08, 2024 | 2.142 |
| August 07, 2024 | 2.113 |
| August 06, 2024 | 2.181 |
| August 05, 2024 | 2.238 |
| August 02, 2024 | 2.228 |
| August 01, 2024 | 2.262 |
| July 31, 2024 | 2.322 |
| July 30, 2024 | 2.241 |
| July 29, 2024 | 2.456 |
| July 26, 2024 | 2.400 |
| July 25, 2024 | 2.379 |
| July 24, 2024 | 2.251 |
| July 23, 2024 | 2.232 |
| July 22, 2024 | 2.272 |
| July 19, 2024 | 2.325 |
| July 18, 2024 | 2.354 |
| July 17, 2024 | 2.381 |
| July 16, 2024 | 2.773 |
| July 15, 2024 | 2.765 |
| July 12, 2024 | 2.725 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.060
Minimum
Aug 12 2024
17.86
Maximum
Oct 31 2023
5.948
Average
4.590
Median
Feb 15 2024
Price to Book Value Benchmarks
| Viking Therapeutics Inc | 8.486 |
| Eli Lilly and Co | 61.18 |
| Amgen Inc | 30.59 |
| Pfizer Inc | 1.901 |
| Novo Nordisk AS | 35.14 |
Price to Book Value Related Metrics
| Price | 41.92 |
| Earnings Yield | -5.30% |
| Market Cap | 2.398B |